Cargando…

9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells

Colorectal cancer (CRC) is one of the most common and lethal types of cancer. Although researchers have made significant efforts to study the mechanisms underlying CRC drug resistance, our knowledge of this disease is still limited, and novel therapies are in high demand. It is urgent to find new ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poloznikov, Andrey, Nikulin, Sergey, Bolotina, Larisa, Kachmazov, Andrei, Raigorodskaya, Maria, Kudryavtseva, Anna, Bakhtogarimov, Ildar, Rodin, Sergey, Gaisina, Irina, Topchiy, Maxim, Asachenko, Andrey, Novosad, Victor, Tonevitsky, Alexander, Alekseev, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696016/ https://www.ncbi.nlm.nih.gov/pubmed/34955846 http://dx.doi.org/10.3389/fphar.2021.777114

Ejemplares similares

ELOVL5 and IGFBP6 genes modulate sensitivity of breast cancer cells to ferroptosis
por: Nikulin, Sergey, et al.
Publicado: (2023)

Effect of the Expression of ELOVL5 and IGFBP6 Genes on the Metastatic Potential of Breast Cancer Cells
por: Nikulin, Sergey, et al.
Publicado: (2021)

Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models()()
por: Ugolkov, Andrey, et al.
Publicado: (2017)

Impedance Spectroscopy as a Tool for Monitoring Performance in 3D Models of Epithelial Tissues
por: Gerasimenko, Tatiana, et al.
Publicado: (2020)

LAMA4-Regulating miR-4274 and Its Host Gene SORCS2 Play a Role in IGFBP6-Dependent Effects on Phenotype of Basal-Like Breast Cancer
por: Shkurnikov, Maxim, et al.
Publicado: (2019)

Highly efficient synthesis of 3,4-diarylbutadiene sulfones using Heck–Matsuda reaction
por: Shurupova, Olga V., et al.
Publicado: (2022)

Towards embedding Caco-2 model of gut interface in a microfluidic device to enable multi-organ models for systems biology
por: Sakharov, Dmitry, et al.
Publicado: (2019)

Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review
por: Kachmazov, Andrei, et al.
Publicado: (2022)

General Method of Synthesis of 5-(Het)arylamino-1,2,3-triazoles via Buchwald–Hartwig Reaction of 5-Amino- or 5-Halo-1,2,3-triazoles
por: Gribanov, Pavel S., et al.
Publicado: (2022)

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer
por: Kuroki, Hiroo, et al.
Publicado: (2019)

Solvent- and transition metal-free amide synthesis from phenyl esters and aryl amines
por: Rzhevskiy, Sergey A., et al.
Publicado: (2019)

Electrical and Gas Sensor Properties of Nb(V) Doped Nanocrystalline β-Ga(2)O(3)
por: Andreev, Matvei, et al.
Publicado: (2022)

Structure–Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors
por: Poloznikov, Andrey A., et al.
Publicado: (2022)

One-Pot Modified Madelung Synthesis of 3-Tosyl- and 3-Cyano-1,2-disubstituted Indoles
por: Sterligov, Grigorii K., et al.
Publicado: (2022)

A Post-Processing Algorithm for miRNA Microarray Data
por: Nersisyan, Stepan, et al.
Publicado: (2020)

ECM–Receptor Regulatory Network and Its Prognostic Role in Colorectal Cancer
por: Nersisyan, Stepan, et al.
Publicado: (2021)

Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A case report
por: Kornietskaya, Anna, et al.
Publicado: (2022)

Clinically relevant GSK-3β inhibitor 9-ING-41 is active as a single agent and in combination with other antitumor therapies in human renal cancer
por: Anraku, Tsutomu, et al.
Publicado: (2020)

GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties
por: Park, Robin, et al.
Publicado: (2021)

Synthesis, Characterization, and Properties of High-Energy Fillers Derived from Nitroisobutylglycerol
por: Rzhevskiy, Sergey A., et al.
Publicado: (2023)

GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents
por: Karmali, Reem, et al.
Publicado: (2017)

Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition
por: Coats, Josh T., et al.
Publicado: (2023)

ExhauFS: exhaustive search-based feature selection for classification and survival regression
por: Nersisyan, Stepan, et al.
Publicado: (2022)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
por: Savyuk, Maria, et al.
Publicado: (2020)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
por: Poloznikov, Andrey A., et al.
Publicado: (2021)

Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression
por: Kemper, Marius, et al.
Publicado: (2021)

Microporous Materials Based on Norbornadiene-Based Cross-Linked Polymers
por: Alentiev, Dmitry A., et al.
Publicado: (2018)

Postoperative Chemotherapy After Surgical Resection of Metachronous Metastases of Colorectal Cancer: A Systematic Review
por: Evdokimova, Sevindzh, et al.
Publicado: (2023)

Case Report: Genetic Alterations Associated with the Progression of Carotid Paraganglioma
por: Pavlov, Vladislav, et al.
Publicado: (2021)

Comprehensive Genetic Study of Malignant Cervical Paraganglioma
por: Snezhkina, Anastasiya, et al.
Publicado: (2023)

Effect of AuPd Bimetal Sensitization on Gas Sensing Performance of Nanocrystalline SnO(2) Obtained by Single Step Flame Spray Pyrolysis
por: Krivetskiy, Valeriy, et al.
Publicado: (2019)

New Allosteric Modulators of AMPA Receptors: Synthesis and Study of Their Functional Activity by Radioligand-Receptor Binding Analysis
por: Golubeva, Elena A., et al.
Publicado: (2023)

Bach1 derepression is neuroprotective in a mouse model of Parkinson’s disease
por: Ahuja, Manuj, et al.
Publicado: (2021)

Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies
por: Odia, Yazmin, et al.
Publicado: (2022)

Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma
por: Hsu, Andrew, et al.
Publicado: (2022)

The Physicochemical Characterization of New “Green” Epoxy-Resin Hardener Made from PET Waste
por: Sterligov, Grigorii K., et al.
Publicado: (2022)

Glycogen Synthase Kinase-3β Inhibition with 9-ING-41 Attenuates the Progression of Pulmonary Fibrosis
por: Jeffers, Ann, et al.
Publicado: (2019)

Lymphatic Dissemination in Prostate Cancer: Features of the Transcriptomic Profile and Prognostic Models
por: Pudova, Elena A., et al.
Publicado: (2023)

Archibald Inglis
Publicado: (1889)

Mallet-ing
Publicado: (1860)

Cannot write session to /tmp/vufind_sessions/sess_7uajk1a6e7hut35oq2i4tk1jk4